- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05903911
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
Study Overview
Detailed Description
The overall purpose of this project is to create a free intervention that can be disseminated widely throughout TNB communities to improve well-being in an easy, accessible way. Development and execution of the Trans Care intervention involves two primary aims:
- Aim 1) Feasibility and acceptability analysis (FAA) [represented by NCT05884307]
- Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy [represented in this study record]
Aim 2 is a RCT in which participants' scores of psychological wellbeing and coping strategies in the intervention vs waitlist control group will be analyzed. Additionally, participants who drop out of the RCT will be asked to complete measures at dropout to determine what dose size of Trans Care (i.e., how many modules) is necessary to have a significant change in mental well-being. Finally, waitlisted participants will be offered the intervention within one month of the completion of data collection.
Aim 2 Hypotheses:
- TNB Participants who received the Trans Care intervention will demonstrate improvement on quantitative measures of psychological well-being, GD symptoms, and coping strategies compared to waitlisted individuals.
- Changes will be maintained at 3 months follow-up indicating that the Trans Care intervention has a sustained impact on improving TNB individuals' coping.
Aim 2 Endpoints:
The primary endpoint of Aim 2 will be to determine if participants who engaged the Trans Care intervention experienced psychological improvement in their mental health as a result of completing the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- University of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Identify as transgender, transsexual, nonbinary, and/or have a transgender history.
- Experience gender dysphoria.
- Time available to commit to completing a 4-5-hour online intervention and 1-2 hours to complete follow up surveys
Exclusion Criteria:
- under 18 years old
- individual does not identify as transgender, transsexual, nonbinary, and/or have a transgender history
- does not experience gender dysphoria
- is unable to commit to the time requirements of the study
- does not have access to an internet compatible device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist Control
|
|
|
Experimental: Trans Care Intervention
|
an educational and interactive website designed to improve coping strategies of TNB individuals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Depression, Anxiety, and Stress Scale (DASS-21) Score
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
DASS-21 is a composite measurement used to assess symptoms of depression, anxiety, and stress in community settings.
The 21-item survey is comprised of three subscales for Depression, Anxiety, and Stress.
Responses are provided on a 4-point Likert scale, Where 0 = Did not apply to me, 1 = applied to me some degree, or some of the time, 2 = applied to me a considerable degree or good part of time, and 3 = applied to me very much or most of the time.
Total possible range of scores is from 0 to 63, with higher scores indicating higher levels of symptoms.
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Change in Gender Congruence and Life Satisfaction Scale (GCLS) Score
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
GCLS measures gender congruence and life satisfaction in a 38-item self assessment, for a total possible range of scores from 38-190 where higher values indicate greater gender congruence, greater gender-related well-being, and greater life satisfaction.
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Change in Modified Gender Minority Stress and Resilience measure (M-GMSRM) Score
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
Total scores are calculated for each scale based on summed values assigned to possible response options.
The first 8 items are scored 0 for "never," 1 for "yes, before age 18," 2 for "yes, after age 18," and 3 for "yes, in the past year."
Scores from these items are then summed where a higher score indicates more frequent and recent experiences of gender related prejudice.
All other items are scored from 0 - 4 according to responses ranging from strongly disagree to strongly agree.
Items within each subscale (i.e., non-affirmation of identity, internalized transphobia, and negative expectations for the future) are summed with high scores indicating greater distress.
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Change in Trans and Nonbinary Coping Measure (TNCM) Score
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
TNCM assesses the unique ways of coping with gender-related stress.
The measure includes six subscales (Social Support/Connection (5 items); Social Activism (4 items); Hope (5 items); Strategic Gender Expression (5 items); Behavioral Avoidance (5 items); Identity Nondisclosure (4 items).
Responses to items are recorded on a 5-point scale from 1 (I do not do this) to 5 (I almost always do this).
Scale items are summed to create subscale scores.
A higher score indicates greater frequency of use of that coping strategy.
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Alcohol Use Disorder Identification Test
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
This is scored from 0-4 where higher scores are indicative of increased dependence on alcohol.
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Number of Days in the Past Week You Consumed Alcohol
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
7 = 7 days, 6 = 6 days, 5 = 5 days, 4 = 4 days, 3 = 3 days, 2 = 2 days, 1 = 1 day, 0 =no days
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Quantity of Alcohol Use
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
How many alcoholic drinks, on average, have you had per day during the pastweek? An alcoholic drink is defined as 1 beer, 1 glass of wine, 1 shot of alcohol, or 1mixed drink. Response options: 5 = 12+ drinks, 4 = 8-11 drinks, 3 = 5-7 drinks, 2 = 3-4 drinks, 1 = 1-2 drinks, 0 =none |
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
|
Change in Multidimensional Gender Dysphoria Measure Scores
Time Frame: before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
The Multidimensional Gender Dysphoria Measure is a 25-item survey each scored from 1 (strongly disagree) to 6 (strongly agree) for a total possible range of scores of 5-30 in each of 5 domains: Body Gender Dysphoria, Social Gender Dysphoria, Variability of Gender Dysphoria, Relief from Gender Dysphoria, and Internalized Gender Normativity.
Higher scores indicate greater gender dysphoria distress.
|
before and after intervention (participants will have up to 1 month to complete intervention), 3 month follow up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stephanie Budge, PhD, LP, University of Wisconsin, Madison
Publications and helpful links
General Publications
- Lindley, L., & Budge, S. L. (2022). Development and validation of the Trans and Nonbinary Coping Measure (TNCM): A measure of trans and nonbinary specific ways of coping with gender-related stress. Psychology of Sexual Orientation and Gender Diversity. Advance online publication. https://doi.org/10.1037/sgd0000618
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-0644: RCT
- A171600 (Other Identifier: UW Madison)
- UW Baldwin Endowment (Other Identifier: UW Madison)
- Protocol Version 10/17/24 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gender Dysphoria
-
University Hospitals Cleveland Medical CenterKerecis Ltd.RecruitingGender Dysphoria, AdultUnited States
-
Region SkaneRecruiting
-
University of ChicagoNot yet recruitingGender Dysphoria, Adult | VaginoplastyUnited States
-
Rigshospitalet, DenmarkRecruitingGender Identity | Gender Incongruence | Gender Dysphoria, AdultDenmark
-
Amsterdam UMC, location VUmcRecruitingGender Dysphoria, AdolescentNetherlands
-
University Hospital, ToulouseCompletedGender Dysphoria, AdolescentFrance
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsEnrolling by invitationGender Dysphoria | Transgender Persons | Transsexualism | Transgenderism | Gender Incongruence | Phalloplasty | Gender Dysphoria, AdultUnited States
-
Centre Hospitalier Henri LaboritRecruitingGender Dysphoria, AdultFrance
-
University of Colorado, DenverCompletedGender Dysphoria, AdolescentUnited States
-
Hospices Civils de LyonCompletedGender Dysphoria Vaginoplasty SexualityFrance
Clinical Trials on Trans Care Web App
-
University of Wisconsin, MadisonActive, not recruitingGender DysphoriaUnited States
-
CEU San Pablo UniversityCompleted
-
Oregon Center for Applied Science, Inc.National Heart, Lung, and Blood Institute (NHLBI)CompletedBlood Pressure | WeightUnited States
-
WSAUD A/SUniversity of South DakotaCompleted
-
HealthconnectSeoul National University Hospital; Seoul National University Bundang Hospital and other collaboratorsUnknown
-
University of Wisconsin, MadisonCompleted
-
University of IowaAlzheimer's AssociationRecruitingChronic Pain | Dementia | Pain Management | Palliative Care | Care Giving BurdenUnited States
-
California State University, NorthridgeNot yet recruitingAlcohol Use | Cannabis Use | Illicit Drug Use | Prescription Opioid Misuse | Nicotine Use
-
University of North Carolina, Chapel HillCompletedPosttraumatic Stress DisorderUnited States
-
SEPAR- EPOCRecruiting